
Metastatic Breast Cancer — Optimizing the Use of Oral Selective Estrogen Receptor Degraders: Part 2
Oncology Today with Dr Neil Love
00:00
Cross-tumor Insights and Novel Targets
Joyce highlights TKD HER2 mutations in lung and PIK3/Pten biology in prostate, linking precision oncology lessons to breast cancer.
Play episode from 02:48
Transcript


